Andrew Diamond Net Worth

The estimated Net Worth of Andrew S Diamond is at least $5.4 Million dollars as of 15 February 2023. Andrew Diamond owns over 13,301 units of 1Life Healthcare stock worth over $389,021 and over the last 4 years he sold ONEM stock worth over $5,007,600. In addition, he makes $0 as Chief Medical Officer at 1Life Healthcare.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Andrew Diamond ONEM stock SEC Form 4 insiders trading

Andrew has made over 8 trades of the 1Life Healthcare stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 13,301 units of ONEM stock worth $219,067 on 15 February 2023.

The largest trade he's ever made was selling 293,185 units of 1Life Healthcare stock on 15 February 2022 worth over $5,007,600. On average, Andrew trades about 40,339 units every 70 days since 2020. As of 15 February 2023 he still owns at least 23,620 units of 1Life Healthcare stock.

You can see the complete history of Andrew Diamond stock trades at the bottom of the page.

Andrew Diamond biography

Dr. Andrew S. Diamond M.D. Ph.D. serves as Chief Medical Officer of the Company. He Served as the National Medical Director since July 2016, of One Medical Group, Inc., a consolidated One Medical PC. From September 2012 to July 2016, Dr. Diamond served as a physician and in various director roles at One Medical Group, Inc., including as Regional Medical Director, West. Dr. Diamond earned a B.S. in Biological Sciences from Stanford University and an M.D. and Ph.D. from the University of Colorado Health Sciences Center

How old is Andrew Diamond?

Andrew Diamond is 49, he's been the Chief Medical Officer of 1Life Healthcare since 2019. There are 11 older and 4 younger executives at 1Life Healthcare. The oldest executive at 1Life Healthcare, Inc. is Mark Blumenkranz, 68, who is the Independent Director.

What's Andrew Diamond's mailing address?

Andrew's mailing address filed with the SEC is C/O 1LIFE HEALTHCARE, INC., ONE EMBARCADERO CENTER, SUITE 1900, SAN FRANCISCO, CA, 94111.

Insiders trading at 1Life Healthcare

Over the last 5 years, insiders at 1Life Healthcare have traded over $573,693,882 worth of 1Life Healthcare stock. The most active insiders traders include Group Management L.L.C.Carl..., Amir Dan Rubin, and Scott C Taylor. On average, 1Life Healthcare executives and independent directors trade stock every 10 days with the average trade being worth of $4,338,939. The most recent stock trade was executed by Bjorn B Thaler on 15 February 2023, trading 13,829 units of ONEM stock currently worth $227,764.

What does 1Life Healthcare do?

1Life Healthcare, Inc. operates a membership-based primary care platform under the One Medical brand. The company has developed a healthcare membership model based on direct consumer enrollment, as well as third-party sponsorship. Its membership model includes seamless access to 24/7 digital health services paired with inviting in-office care routinely covered under health insurance programs. The company also offers administrative and managerial services pursuant to contracts with physician-owned professional corporations or One Medical Entities. As of December 31, 2021, it had 703,000 consumer and enterprise members, and 33,000 At-Risk members; 182 medical offices in 25 markets; and 8,500 enterprise clients in the United States. The company was incorporated in 2002 and is headquartered in San Francisco, California.

Complete history of Andrew Diamond stock trades at 1Life Healthcare

1Life Healthcare executives and stock owners

1Life Healthcare executives and other stock owners filed with the SEC include:

• Amir Rubin,
  Chairman of the Board, President, Chief Executive Officer
• Bjorn Thaler,
  Chief Financial Officer
• Kimber Lockhart,
  Chief Technology Officer
• Amir Dan Rubin MBA,
  Chair, CEO & Pres
• Bjorn B. Thaler,
  Chief Financial Officer
• Kalen Holmes,
  Independent Director
• Paul Auvil,
  Independent Director
• David Kennedy,
  Independent Director
• Freda Lewis-Hall,
  Independent Director
• Mark Blumenkranz,
  Independent Director
• David Singer,
  Independent Director
• Robert Schmid,
  Independent Director
• Bruce Dunlevie,
  Lead Independent Director
• Andrew Diamond,
  Chief Medical Officer
• Lisa Mango,
  General Counsel and Corporate Secretary
• Jenni Vargas,
  Chief Strategy Officer
• Rajneesh Behal M.D., MPH,
  Chief Quality Officer
• Dr. Andrew S. Diamond M.D., Ph.D.,
  Chief Medical Officer
• Christine Morehead,
  Chief People Officer
• Doug Sweeny,
  Chief Marketing Officer
• Lisa A. Mango,
  Gen. Counsel & Corp. Sec.
• Ken Goff,
  VP of Investor Relations
• Stuart Parmenter,
  Chief Technology Officer
• Scott C Taylor,
  
• Vikas Agarwal,
  Chief Accounting Officer
• Morgan Investment Managemen...,
  10% owner
• Investment Partners Xii L P...,
  10% owner
• Digital Growth Fund Ii L.P....,
  10% owner
• Group Management L.L.C.Carl...,
  
• Capital Management Co. V, L...,
  
• Mary Ann Tocio,